Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of AA4500 in Peyronie's Disease
NCT01430169Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Sep 2011
- Primary completion
- Nov 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Started Sep 2011; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT01430169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430169.